KuangChi Science Limited provided consolidated earning guidance for year ended 31 December 2023. For the year ended 31 December 2023, the Group expects that it may record a significant decrease in net loss for the year ended 31 December 2023 (?FY2023?) with a net loss ranging from approximately HKD 6,000,000 to HKD 8,000,000 for FY2023 as compared to a net loss of approximately HKD 67,912,000 for the year ended 31 December 2022 (?FY2022?). The expected decrease in the unaudited net loss of the Group is primarily attributable to: During the year, the Group disposed of its equity in Irisity AB, an overseas listed company, and recognized a loss on changes in fair value of approximately HKD 600,000 (FY2022: a loss on changes in fair value of approximately HKD 19,500,000); During FY2023, the Group improved its marketing strategy and further reduced its operating expenses through effective control, with a significant decrease in selling and marketing expenses of approximately HKD 19,700,000; and During FY2023, the Group continuously enhanced its internal control, strictly cut costs and increased efficiency, resulting in a significant decrease in administrative expenses of approximately HKD 10,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 HKD | +9.09% | +1.69% | -41.18% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.18% | 47.24M | |
-19.53% | 177B | |
-3.23% | 159B | |
+2.05% | 153B | |
+5.13% | 100B | |
+9.84% | 81.1B | |
+22.85% | 75.87B | |
-8.81% | 69.81B | |
-31.57% | 45.59B | |
-9.69% | 42.96B |
- Stock Market
- Equities
- 439 Stock
- News KuangChi Science Limited
- KuangChi Science Limited Provides Consolidated Earning Guidance for Year Ended 31 December 2023